B
BCDA
Biocardia Inc
0.8827
-0.0383-4.16%Opening11:21 10/26 EDT
OPEN/PREV CLOSE0.9300/0.9210
TODAY RANGE0.8699-0.9300
VOL85.32K
MARKET CAP13.36M
52 WEEK RANGE0.7500-1.800
AVG VOL (3M)252.15K
% TURNOVER0.56%
TURNOVER--
P/E (TTM)-1.1549
% RANGE6.53%
EPS(TTM)-0.7643
P/E(FORWARD)-1.4011
P/B4.898
BVPS0.1802
DIVIDEND--
P/S96.03
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.82M
SHARES OUTSTANDING15.14M
NEXT EARNINGS11/10-11/16
FREE FLOAT12.26M
LOT SIZE1
EX-DATE05/30/2024
News
Press Releases
Financial Reports
Profile
TipRanks·10/19 13:41
BioCardia announces FDA acceptance of Helix pre-submission package
TipRanks·10/19 13:38
BioCardia Advances Helix Catheter Toward FDA Clearance
TipRanks·10/07 13:33
BioCardia Advances CardiAMP HF II Heart Failure Trial
TipRanks·10/01 13:50
BioCardia Submits Revised FDA De Novo for Helix
TipRanks·09/23 13:51
BioCardia Advances Regulatory Milestones for Cardiovascular Therapies
TipRanks·09/23 13:20
BioCardia provides update on near term milestones for CardiAMP, Helix
TipRanks·09/10 13:23
BioCardia Highlights Therapeutic Pipeline at Investor Conference
TipRanks·08/24 13:00
BioCardia gets FDA confirmation of Helix meeting minutes
TipRanks·08/24 13:00
BioCardia Advances Helix Catheter Toward De Novo Approval
TipRanks·08/21 20:59
BioCardia Receives Nasdaq Notice on Minimum Bid Price
TipRanks·08/13 10:20
Analysts’ Top Healthcare Picks: BioCardia (BCDA), Unicycive Therapeutics (UNCY)
TipRanks·08/13 00:10
BioCardia Earnings Call Highlights Regulatory Momentum
Seeking Alpha·08/12 20:23
BioCardia GAAP EPS of -$0.13 beats by $0.05
Same Industry
Name/Symbol
Change%
Price